Therapeutic targeting of breast cancer and host immune responses at inflection points in the disease trajectory

Ended Cooperative Agreement Awarded Last action

Award ID
W81XWH2120031
Recipient
Awarding agency
Obligated
$9,583,033

Award facts

Assistance listing
12.420 Military Medical Research and Development
Completion date
Originally
Place of performance
Durham, NC 27708, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Original award $9,583,033

Subawards

Subrecipient Amount Awarded
Brigham & Womens Hospital Inc. Therapeutic targeting of breast cancer and host immune responses at inflection points in T $259,854
Brigham & Womens Hospital Inc. $230,580
Cedars-Sinai Medical Center $211,382
Cedars-Sinai Medical Center PROJECT 1: Profiling the human breast tumor ecosystem to identify regulators of anti-tumor immunity (Knott Lab, Cedars-Sinai) Specific Aim 1: Determine the… $83,079
Weill Medical College Of Cornell University Specific Aim 1. Identify TNBC organoids naturally harboring PTENDDel and create a PTENMut TNBC 3D model Milestone #1: Developing TNBC organoids to generate 3D… $84,750
Weill Medical College Of Cornell University Aim 1) Determine the role of HIF-1α in the induction of immune-stimulatory versus immune-suppressive pathways by RT 1A - Generation of HIF-1α deficient… $25,260

Quick answers

Who received award W81XWH2120031?

W81XWH2120031 was awarded to Duke University by Defense Health Agency (Department of Defense) on September 15, 2021.

How much is award W81XWH2120031 worth?

$9,583,033 has been obligated on W81XWH2120031.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login